KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Inventory (2018 - 2026)

Alnylam Pharmaceuticals filings provide 9 years of Inventory readings, the most recent being $84.0 million for Q1 2026.

  • On a quarterly basis, Inventory rose 28.12% to $84.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $84.0 million, a 28.12% increase, with the full-year FY2025 number at $82.7 million, up 5.36% from a year prior.
  • Inventory hit $84.0 million in Q1 2026 for Alnylam Pharmaceuticals, up from $82.7 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $131.9 million in Q1 2023 to a low of $65.6 million in Q1 2025.
  • Median Inventory over the past 5 years was $84.0 million (2026), compared with a mean of $90.7 million.
  • The widest YoY moves for Inventory: up 67.96% in 2023, down 30.87% in 2023.
  • Alnylam Pharmaceuticals' Inventory stood at $129.0 million in 2022, then tumbled by 30.87% to $89.1 million in 2023, then dropped by 11.93% to $78.5 million in 2024, then grew by 5.36% to $82.7 million in 2025, then increased by 1.58% to $84.0 million in 2026.
  • The last three reported values for Inventory were $84.0 million (Q1 2026), $82.7 million (Q4 2025), and $75.4 million (Q3 2025) per Business Quant data.